Abstract: Methods and apparatus for packing, including single pixel data strings, and playback tracking of informative data, e.g., audio signals, associated with graphics. To maximize the signal-to-noise ratio during data recovery, a Read sensor is kept substantially on-center of each data block throughout reading. A Print-and-Read ink-jet embodiment carriage mechanism in conjunction with the paper feed mechanism keeps the Read sensor on track center as misalignment information has been determined beforehand or in real time for active track servoing. Additional functionalities are incorporated in scanning ink-jet class of printers so that they can further operate as informative data recovery or retrieval systems for digitized data on graphical data images. In another embodiment, a digital camera itself is provided with additional functionalities to operate as a recovery and playback device for prints containing informative data.

Abstract: The present invention is related to antibodies directed to various drugs of abuse and uses of such antibodies. In preferred embodiments, the drugs of abuse are amphetamine, methamphetamine, or phencyclidine (PCP). In particular, in accordance with the present invention, there are provided fully man monoclonal antibodies directed to drugs of abuse. Nucelotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR3 or CDR1 through CDR3, are provided. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also provided.

Abstract: A method for monitoring a dose of a silicon bearing implant is described. The method includes introducing a first implant species through a surface of a semiconductor substrate at a first does of energy level and introducing a silicon bearing species through the surface of the semiconductor substrate at a second dose and a second energy level. The method anneals the semiconductor substrate and measures a sheet resistance value of the surface of the semiconductor substrate. The method also determines the second dose value based upon the surface resistance value.

Abstract: A method of controlling a robot (32) includes the steps of selecting an initial configuration from at least one of a first, second, and third sets to position a TCP at a starting point (44) along a path (33) and selecting a final configuration different than the initial configuration to position the TCP at an ending point (46). Next, the TCP moves from the starting point (44) while maintaining the initial configuration, approaches the singularity between a first point (48) and a second point (50), and selects one of the axes in response to reaching the first point (48). The angle for the selected axis is interpolated from the first point (48) to the second point (50). After the interpolation, the angles about the remaining axes are determined and positions the arms in the final configuration when the TCP reaches the second point (50) and moves to the ending point (46) while maintaining the final configuration.

Abstract: Compositions having high moisture resistance and flexibility comprise an organic component and a filler. The organic component comprises a long-chain cycloaliphatic epoxy resin, a short-chain cycloaliphatic epoxy resin, a cyanate ester, and a Lewis acid catalyst. Preferably the organic component further comprises a Bronsted acid co-catalyst and/or a flexibilizing modifier. The compositions are useful in various semiconductor applications, including as die attach adhesives, underfills, encapsulants, via fills, prepreg binders, polymer solder masks and polymer bumps on flip chip or BGA assemblies.

Abstract: The invention is based in part on the discovery that nonselective ? agonists that possess ? receptor-mediated effects in addition to their ? agonist effects can decrease cocaine self-administration more effectively and with fewer undesirable side effects than can highly selective ? agonists. The invention includes a number of new compounds having both nonselective ? opioid receptor agonist activity and additional activity at ? opioid receptors. These compounds are useful for the treatment of cocaine abuse, and can also be radiolabeled for use as imaging agents, e.g., the N-fluoroalkyl and iodoalkyl derivatives can be used, respectively, for positron emission tomography (PET) and single photon computed tomography (SPECT) brain imaging.

Abstract: A method and apparatus are disclosed for generating a second clock signal, having a second effective clock frequency, from a first clock signal, having a first effective clock frequency. Clock pulses of the first clock signal are counted to generate a count value. When the count value reaches a predetermined blanking value, a blanking signal is generated. The blanking signal blanks at least one clock pulse of the first clock signal. The process is repeated multiple times at a predetermined rate corresponding to the predetermined blanking value to generate the second clock signal.

Abstract: The present invention provides methods for the amplification of nucleic acid molecules. Methods for amplifying target polynucleotides, including mRNA, using oligonucleotides, DNA and RNA polymerases are provided. The invention further provides compositions and kits for practicing the methods, as well as methods which use the amplification products.

Abstract: This invention discloses structures of organic materials-based semiconductor devices and methods for the fabrication of such devices. According to this invention, each of the devices has a first part and a second part. The first part has at least a first organic semiconductor material layer deposited on a first electrode and the second part has at least a second organic semiconductor material layer deposited on a second electrode. Said device is formed by assembling the two individual parts together. Each part maybe fabricated separately and consists of an electrode coated with semiconductor organic materials required by the function of the desired device. A schematic diagram in the FIG. 3 shows a first part (11) consisting of a first substrate (13), a first electrode (14) and at least one layer of organic materials (15); the second part (12) of the device consisting of the second substrate (16), a second electrode (17) with at least a layer of organic materials (18).

Abstract: Provided herein are methods for making and screening antibodies. Methods may include injecting a plurality of antigens or nucleic acids encoding antigens into a host. Methods may also include using fusion proteins of an antigen to a carrier protein for preparing and/or screening antibody preparations. The methods may be used for simultaneous making and/or screening of large numbers of different antibodies.

Abstract: A three-dimensional molecular assembly and method of formation are provided. The molecular assembly is formed on a substrate. The molecular assembly comprises: a first monolayer of seed molecules for initiating self-assembled molecular growth, the first monolayer formed on the substrate; a second monolayer of active molecules comprising a plurality of rotor and stator moieties, with one rotor moiety supported between two stator moieties, the second monolayer of active molecules formed on the first monolayer of seed molecules, with a one-to-one correspondence between molecules in the first monolayer and the second monolayer; a third monolayer of spacer molecules, formed on the second monolayer of active molecules, with a one-to-one correspondence between molecules in the second monolayer and the third monolayer; and a plurality of alternating second monolayers and third monolayers having the one-to-one correspondence.

Abstract: The present invention relates to polynucleotides associated with angiogenesis-related disorders. The present invention also relates to canine endostatin genes, novel genes associated with angiogenesis-related disorders, such as cancer. The invention encompasses endostatin nucleic acids, recombinant DNA molecules, cloned genes or degenerate variants thereof, endostatin gene products and antibodies directed against such gene products, cloning vectors containing mammalian endostatin gene molecules, and hosts that have been genetically engineered to express such molecules. The invention further relates to methods for the identification of compounds that modulate the expression of endostatin genes and gene products and to using such compounds as therapeutic agents in the treatment of angiogenesis-related disorders, e.g., cancer. The invention also relates to methods for the diagnostic evaluation, genetic testing and prognosis of angiogenesis-related disorders, e.g.

Abstract: Catalysts have a catalytic substrate impregnated with a catalytically active metal, and are prepared by adjusting the pH of a solution of catalytic metal ions to precipitate a layer of catalytic metal on the support.

Abstract: A method for generating mid-infrared light by maintaining multiple quantum well (MQW) structures based on the alloy systems PbSrZ and PbSnZ, where Z is S, Se, or Te, at temperatures in the range of from about 5° C. to about 55° C. and pumping the MQW structures with a shorter wavelength laser pump beam or with an electrical current is provided.

Abstract: An organic light-emitting device (OLED) in which pyrylium salt or its derivative, such as thiapyrylium, selenapyrylium, or telluropyrylium, is used as a charge transport material and/or at least a dopant or principal component in a charge transport layers.

Abstract: The invention relates to a method of fracturing a subterranean formation at reduced surface pressure including injecting into a wellbore an energized fracturing fluid based on a liquid medium having a density higher than 1.2 g/cm3.

Abstract: The present invention provides pharmaceutical compositions and novel compounds useful in the treatment of conditions mediated by CCR2, MCP-1 or the interaction thereof. The compounds of the present invention are pyrrolidinones and pyrrolidine-thiones.

Abstract: A modular and configurable display driver for driving a bistable liquid crystal display. The driver has configurable outputs set by a plurality of configuration bits for driving rows or columns of various displays configurations. Thus, the driver can be economically mass produced for use in many products.